Par Drugs and Chemicals Limited (NSE:PAR)

Par Drugs and Chemicals Revenue

Par Drugs and Chemicals had revenue of 274.32M INR in the quarter ending September 30, 2026, a decrease of -4.28%. This brings the company's total for the last twelve months to 1.08B, up 9.40% year-over-year. In the fiscal year ending March 31, 2026, Par Drugs and Chemicals had annual revenue of 1.04B with 2.66% growth. That makes Par Drugs and Chemicals the 36,777th largest company in the world by revenue and 3,182nd in India.

• Revenue (ttm): 1.08B
• Revenue Growth: +9.40%
• P/S Ratio: 1.28
• Revenue / Employee: 9.12M
• Employees: 118
• Market Cap: 1.45B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 747.49M 72.1%
• Export 280.49M 27.1%
• Unallocated 8.57M 0.8%

Fiscal year ended Mar 31, 2026 See the full Par Drugs and Chemicals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.04B	26.82M	2.66%
Mar 31, 2025	1.01B	53.33M	5.58%
Mar 31, 2024	956.40M	-1.08M	-0.11%
Mar 31, 2023	957.49M	206.74M	27.54%
Mar 31, 2022	750.74M	143.23M	23.58%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error